TY - JOUR
T1 - Spinal cord stimulation for refractory chronic angina pectoris
T2 - Influence on quality of life
AU - Fumero, Andrea
AU - Rapati, Dino
AU - Diso, Sabina
AU - Lapenna, Elisabeth
AU - Alfieri, Ottavio
PY - 2007/8
Y1 - 2007/8
N2 - Percutaneous coronary revascularization, coronary artery bypass graft surgery and medical management are nowadays very effective in treating coronary artery disease. Nevertheless, the number of patients affected by refractory chronic angina pectoris is increasing. Epidemiological estimates for refractory angina pectoris predict the diagnosis of more than 100,000 patients each year in the USA and approximately 50,000 in Europe. Spinal cord stimulation is a valuable therapeutic option for patients who have failed multiple percutaneous and surgical revascularizations and who are not eligible for further revascularization procedures. The aim of this study is to assess the benefits, in terms of quality of life, of spinal cord stimulation in no-option patients affected by refractory angina pectoris.
AB - Percutaneous coronary revascularization, coronary artery bypass graft surgery and medical management are nowadays very effective in treating coronary artery disease. Nevertheless, the number of patients affected by refractory chronic angina pectoris is increasing. Epidemiological estimates for refractory angina pectoris predict the diagnosis of more than 100,000 patients each year in the USA and approximately 50,000 in Europe. Spinal cord stimulation is a valuable therapeutic option for patients who have failed multiple percutaneous and surgical revascularizations and who are not eligible for further revascularization procedures. The aim of this study is to assess the benefits, in terms of quality of life, of spinal cord stimulation in no-option patients affected by refractory angina pectoris.
KW - Quality of life
KW - Refractory chronic angina
KW - Spinal cord
KW - Spitzer index
UR - http://www.scopus.com/inward/record.url?scp=34548447021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548447021&partnerID=8YFLogxK
U2 - 10.1586/14737167.7.4.343
DO - 10.1586/14737167.7.4.343
M3 - Article
C2 - 20528416
AN - SCOPUS:34548447021
VL - 7
SP - 343
EP - 349
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
SN - 1473-7167
IS - 4
ER -